Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
25 Apr 2023 16:06 CEST |
MITHRA | Mithra Releases Invitation to its General Shareholders’ Meeting | 20103015 Pharmaceuticals | General meeting / Board Meeting |
18 Apr 2023 11:16 CEST |
MITHRA | Mithra releases 2022 Annual Report | 20103015 Pharmaceuticals | Corporate life |
27 Sep 2022 09:40 CEST |
MITHRA | Mithra 2022 Half Year Results | 20103015 Pharmaceuticals | Commercial results |
17 Aug 2022 16:10 CEST |
MITHRA | Mithra obtains funding for up to EUR 100 Million from existing investors and repurchases EUR 34.1 million of its convertible bonds due 2025 at a discount to par | 20103015 Pharmaceuticals | Other financial transaction |
17 Aug 2022 15:39 CEST |
MITHRA | Mithra Completes a EUR 23.5 Million Private Placement | 20103015 Pharmaceuticals | Change in Capital |
17 Aug 2022 15:31 CEST |
MITHRA | Mithra 2021 Full Year Results | 20103015 Pharmaceuticals | Commercial results |
17 Aug 2022 15:22 CEST |
MITHRA | Mithra résultats semestriels 2021 | 20103015 Pharmaceuticals | Commercial results |
17 Aug 2022 15:18 CEST |
MITHRA | Mithra 2021 Half Year Results | 20103015 Pharmaceuticals | Commercial results |
09 Mar 2021 07:54 CET |
MITHRA | Mithra annonce ses résultats annuels 2020 | 20103015 Pharmaceuticals | Commercial results |
09 Mar 2021 07:52 CET |
MITHRA | Mithra Reports Full Year 2020 Financial Results | 20103015 Pharmaceuticals | Commercial results |
21 Jan 2021 15:30 CET |
MITHRA | Mithra announces placement of EUR 125 million convertible bonds due 2025 | 20103015 Pharmaceuticals | Other financial transaction |
21 Jan 2021 15:26 CET |
MITHRA | First Half 2020 financial report | 20103015 Pharmaceuticals | Corporate life |
18 Jun 2020 20:45 CEST |
MITHRA | Mithra Successfully Raises EUR 65.0 Million By Means of a Private Placement via an Accelerated Bookbuild Offering | 20103015 Pharmaceuticals | Change in Capital |
18 Jun 2020 14:39 CEST |
MITHRA | Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy | 20103015 Pharmaceuticals | Change in Capital |
09 Mar 2020 07:30 CET |
MITHRA | Mithra Reports Full Year 2019 Financial Results | Pharmaceuticals | Corporate life |
09 Mar 2020 07:30 CET |
MITHRA | Mithra annonce ses résultats annuels 2019 | Pharmaceuticals | Corporate life |
10 Jan 2020 10:00 CET |
MITHRA | E4 Paves the Road Towards a Revolutionary Era of Environmental Friendly Medicines | Pharmaceuticals | Trends / Analyses |
01 Oct 2019 13:13 CEST |
MITHRA | MITHRA SUCESSFULLY RENEGOTIATES EARNOUT PAYMENTS | Pharmaceuticals | Alliances and agreements |
01 Oct 2019 13:12 CEST |
MITHRA | MITHRA SIGNS LANDMARK CONTRACT FOR ESTELLE® IN THE UNITED STATES WITH MAYNE PHARMA | Pharmaceuticals | Alliances and agreements |
19 Sep 2019 11:17 CEST |
MITHRA | First half 2019 financial report | Pharmaceuticals | Corporate life |
19 Sep 2019 07:49 CEST |
MITHRA | Mithra Announces 2019 Half Year Results | Pharmaceuticals | Corporate life |
08 Apr 2019 11:19 CEST |
MITHRA | Mithra Releases 2018 Annual Report and Invitation to its General Shareholders’ Meeting | Pharmaceuticals | Corporate life |
01 Mar 2019 08:43 CET |
MITHRA | Mithra Reports 2018 Annual Results | Pharmaceuticals | Corporate life |
30 Jan 2019 11:27 CET |
MITHRA | Mithra annonce les premiers résultats positifs pour l’étude de phase III du contraceptif oral Estelle® aux États-Unis/Canada | Pharmaceuticals | - |
22 Jan 2019 18:00 CET |
MITHRA | MITHRA REPORTS 2017 ANNUAL RESULTS | Pharmaceuticals | Corporate life |
22 Jan 2019 14:59 CET |
MITHRA | Blockbuster potentiel en périménopause avec un nouveau produit candidat à base d’E4 et accélération du programme de Phase III pour Donesta | Pharmaceuticals | - |
22 Jan 2019 14:55 CET |
MITHRA | MITHRA ANNONCE SES RÉSULTATS SEMESTRIELS 2018 | Pharmaceuticals | - |
21 Sep 2017 07:30 CEST |
MITHRA | Mithra announces 2017 half year results | Pharmaceuticals | - |
21 Sep 2017 07:30 CEST |
MITHRA | Mithra publie ses résultats semestriels 2017 | Pharmaceuticals | - |
28 Jun 2017 07:30 CEST |
MITHRA | Mithra signe un accord de licence et d’approvisionnement exclusif avec Fuji Pharma pour Donesta® au Japon et en ASEAN | Pharmaceuticals | - |
28 Jun 2017 07:30 CEST |
MITHRA | Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and ASEAN | Pharmaceuticals | - |